XHKG
0829
Market cap94mUSD
Oct 09, Last price
0.23HKD
1D
0.44%
1Q
45.57%
Jan 2017
-61.02%
IPO
-89.07%
Name
Shenguan Holdings (Group) Ltd
Chart & performance
P/E
—
P/S
0.62
EPS
—
Div yield, %
17.47%
Shrs. gr., 5y
—
Rev. gr., 5y
1.25%
Revenues
1.02b
+0.64%
Net income
-70m
L
CFO
-93m
L-35.30%
Dividend
Jun 10, 20250.04 HKD/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Shenguan Holdings (Group) Limited operates as an investment holding company, with its core business centered on the manufacturing and global distribution of edible collagen sausage casings. The company serves markets across Mainland China, the broader Asian region, and various international territories. Beyond casings, Shenguan diversifies its manufacturing portfolio to include a range of products intended for human consumption and application. This includes pharmaceuticals and their intermediates, various food items, specialized skin care and health products, bioactive collagen solutions, and precision fine chemicals. Established in 2009, the firm is headquartered in Causeway Bay, Hong Kong. Shenguan Holdings (Group) Limited is a subsidiary of Rich Top Future Limited.
Key people
Yaxian Zhou
Executive Chairman of the Board, President · since 2009
Yunxi Mo
Vice President, Executive Director
Jinpei Wen
Vice President · since 2010
Yuk Yeung Ng
Financial Controller, Company Secretary · since 2009
Chenglin Li
Executive Director · since 2023
Junqi Sha
Executive Director · since 2023
Jee keong Low
Non-Executive Director · since 2009
Qinguo Meng
Independent Non-Executive Director · since 2009
Independent Non-Executive Director · since 2009
Xiaoxiong Zhou
Independent Non-Executive Director · since 2023
Headquarters & legal address
c/o CONYERS TRUST COMPANY (CAYMAN) LIMITED, Cricket Square, Hutchins Drive, P.O. Box 2681
Grand Cayman KY1-1111
KY
Grand Cayman KY1-1111
KY
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||